Intellia Therapeutics Correlations

NTLA Stock

USD 9.31 0.31 3.44%

The current 90-days correlation between Intellia Therapeutics and Editas Medicine is 0.4 (i.e., Very weak diversification). The correlation of Intellia Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Intellia Therapeutics Correlation With Market

Modest diversification

The correlation between Intellia Therapeutics and DJI is 0.28 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Intellia Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Intellia Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

For information on how to trade Intellia Stock refer to our How to Trade Intellia Stock guide.

Moving together with Intellia Stock

0.75	CDIOW	Cardio Diagnostics	Pair Corr
0.72	ELVN	Enliven Therapeutics	Pair Corr
0.65	ASMB	Assembly Biosciences Earnings Call This Week	Pair Corr
0.77	CDIO	Cardio Diagnostics	Pair Corr
0.79	CRNX	Crinetics Pharmaceuticals	Pair Corr
0.65	MSFT	Microsoft Aggressive Push	Pair Corr

Moving against Intellia Stock

0.6	GE	GE Aerospace	Pair Corr
0.56	PLX	Protalix Biotherapeutics	Pair Corr
0.55	WM	Waste Management	Pair Corr
0.42	LUCD	Lucid Diagnostics	Pair Corr
0.34	MLSS	Milestone Scientific Earnings Call This Week	Pair Corr
0.68	MMM	3M Company	Pair Corr
0.6	CVX	Chevron Corp	Pair Corr
0.54	JNJ	Johnson Johnson Sell-off Trend	Pair Corr
0.47	T	ATT Inc Sell-off Trend	Pair Corr
0.46	XOM	Exxon Mobil Corp Earnings Call Next Week	Pair Corr
0.37	IBM	International Business	Pair Corr
0.31	CSCO	Cisco Systems	Pair Corr

Related Correlations Analysis

	EDIT	CRBU	CRSP	VERV	BEAM	FATE	VRTX	DNA	PRME	SANA
EDIT		-0.26	0.77	0.18	0.55	-0.07	0.4	-0.1	0.06	0.05	EDIT
CRBU	-0.26		-0.16	-0.18	0.19	0.93	-0.8	0.32	0.8	-0.28	CRBU
CRSP	0.77	-0.16		0.42	0.77	0.06	0.37	0.16	0.18	0.12	CRSP
VERV	0.18	-0.18	0.42		0.46	-0.06	0.21	0.81	0.2	0.49	VERV
BEAM	0.55	0.19	0.77	0.46		0.4	0.04	0.38	0.38	-0.02	BEAM
FATE	-0.07	0.93	0.06	-0.06	0.4		-0.68	0.38	0.81	-0.35	FATE
VRTX	0.4	-0.8	0.37	0.21	0.04	-0.68		-0.25	-0.72	0.16	VRTX
DNA	-0.1	0.32	0.16	0.81	0.38	0.38	-0.25		0.58	0.37	DNA
PRME	0.06	0.8	0.18	0.2	0.38	0.81	-0.72	0.58		0.04	PRME
SANA	0.05	-0.28	0.12	0.49	-0.02	-0.35	0.16	0.37	0.04		SANA
	EDIT	CRBU	CRSP	VERV	BEAM	FATE	VRTX	DNA	PRME	SANA

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

FATE	+ 0.93	CRBU
DNA	+ 0.81	VERV
PRME	+ 0.81	FATE
PRME	+ 0.8	CRBU
CRSP	+ 0.77	EDIT
BEAM	+ 0.77	CRSP

High negative correlations

VRTX	- 0.8	CRBU
PRME	- 0.72	VRTX
VRTX	- 0.68	FATE
SANA	- 0.35	FATE
SANA	- 0.28	CRBU
CRBU	- 0.26	EDIT

Risk-Adjusted Indicators

There is a big difference between Intellia Stock performing well and Intellia Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Intellia Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
EDIT	6.56	0.76	0.07	0.14	7.94	(8.25)	12.20	(9.30)	119.53
CRBU	3.00	(0.78)	0.00	(0.76)	0.00	0.00	5.26	(7.09)	17.85
CRSP	2.59	0.03	0.00	(0.04)	0.00	0.00	5.26	(4.81)	19.32
VERV	4.52	0.23	0.03	0.06	5.07	(4.92)	11.11	(8.25)	30.05
BEAM	3.44	(0.10)	0.00	(0.15)	0.00	0.00	7.58	(8.18)	23.04
FATE	4.68	(0.76)	0.00	(0.45)	0.00	0.00	9.29	(9.56)	22.21
VRTX	1.34	0.14	0.07	7.20	2.58	(1.24)	2.53	(2.46)	12.31
DNA	5.75	0.04	0.00	(0.05)	0.00	0.00	12.92	(9.86)	31.71
PRME	4.53	(0.24)	0.00	(0.15)	0.00	0.00	10.03	(9.28)	25.37
SANA	7.56	1.66	0.22	0.58	6.10	(10.29)	10.15	(11.52)	178.30

Intellia Therapeutics Corporate Management

JD Esq	General VP	Profile
Jennifer Doudna	Founder Board	Profile
Derek Hicks	Executive Officer	Profile
Andrew May	Founder Board	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC